These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10137544)

  • 41. How do states buy health insurance for their own employees?
    Maciejewski ML; Dowd BE; Feldman R
    Manag Care Q; 1997; 5(3):11-9. PubMed ID: 10169758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 43. Easing the pain. Slowing prescription drug expense helps rein in costs for large employers.
    Zigmond J
    Mod Healthc; 2006 Dec; 36(48):30. PubMed ID: 17183814
    [No Abstract]   [Full Text] [Related]  

  • 44. Designing benefits that are good for employees and for business.
    Kreig J; Hergenrader R
    Health Care Strateg Manage; 1997 Oct; 15(10):1, 21-3. PubMed ID: 10173409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular medicine, the Medicare drug benefit, and the need for cost control.
    Gillick MR
    J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-funding health insurance for small employers: is it the right way to go?
    Halterman SL
    Empl Benefits J; 2000 Sep; 25(3):3-7. PubMed ID: 11116646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consumers face higher costs as health plans seek to control drug spending.
    Mays GP; Hurley RE; Grossman JM
    Issue Brief Cent Stud Health Syst Change; 2001 Nov; (45):1-4. PubMed ID: 11865903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Getting employees to say no ... to smoking.
    Bus Health; 1993 Mar; 11(3):42-4, 46. PubMed ID: 10124595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4 payer trends to control specialty pharmacy costs.
    Studin I
    Manag Care; 2012 May; 21(5):27-9. PubMed ID: 22670484
    [No Abstract]   [Full Text] [Related]  

  • 51. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 53. Developing an effective generic prescription drug program.
    Jones JD
    Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rising health care costs: employers respond.
    Proestakes G
    Healthplan; 2002; 43(3):34-6. PubMed ID: 12068729
    [No Abstract]   [Full Text] [Related]  

  • 55. Health risk management: well-being for the employee and the bottom line.
    Haltom C
    Benefits Q; 2005; 21(3):7-10. PubMed ID: 16248225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The humanizing of healthcare delivery. Tackling the high costs and closing the loopholes.
    Kerry J
    Healthc Leadersh Rep; 2004 Mar; 12(3):4-12. PubMed ID: 15106329
    [No Abstract]   [Full Text] [Related]  

  • 57. Control of prescription costs--is it possible?
    Renaud PN
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintaining a mission. Medicaid plans focus on pharmaceutical care.
    Gearon CJ
    Healthplan; 2002; 43(4):54-6. PubMed ID: 12221779
    [No Abstract]   [Full Text] [Related]  

  • 59. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk contractors take aim at skyrocketing drug costs.
    Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.